BREATHTEC BIOMEDICAL, INC.
GAINESVILLE, FLORIDA

Breathtec’s mission is to develop technologies that use biomarkers in the breath to screen for early signs of diseases such as lung & breast cancers, infectious diseases, diabetes, liver disease, and more. We are focused on developing a low-cost, non-invasive, portable hand-held device to be used by clinician’s in the office, clinic or hospital setting, or by agents screening for infectious diseases at national border entry points (ie: airports). Enter your email to get news alerts from Breathtec Biomedical. Breathtec’s mission is to develop technologies that use biomarkers in the breath to screen for early signs of diseases such as lung & breast cancers, infectious diseases, diabetes, liver disease, and more. We are focused on developing a low-cost, non-invasive, portable hand-held device to be used by clinician’s in the office, clinic or hospital setting, or by agents screening for infectious diseases at national border entry points (ie: airports). Enter your email to get news alerts from Breathtec Biomedical. Enter your email to get news alerts from Breathtec Biomedical. The Company ‹ Mass Spectrometry (MS) helps identify amount and type of molecules in breath sample. Breathtec Biomedical Inc. (“Breathtec”) aims to propel development and commercialization of breath analysis screening technologies. The Company is actively pursuing multiple, alternative research efforts into FAIMS technology. Enter your email to get news alerts from Breathtec Biomedical. Dr. Costanzo enjoys a passion for science that has directed his career path firmly into the field of analytical chemistry. Over the past five years he has investigated a variety of advanced experimental methodologies and instrumentation with the Yost Research Group at the University of Florida. During this period he utilized UV spectroscopy to help in standardizing procedures for manufacturing respiratory medications, employed novel ion mobility spectrometric techniques and devices to analyze exhaled breath, and performed multiple metabolomics studies of melanoma. Through his efforts, he acquired a vast knowledge of analytical techniques and methodologies and an immense desire for scientific progress. Previously, Costanzo obtained his Bachelor of Science in chemistry at the State University of New York (Buffalo). During this period he conducted research under Dr. Troy Wood utilizing mass spectrometry to examine products of enzymatic protein digestion in the interest of studying metabolic markers of autism in children. Upon graduation in 2010 he moved to the University of Florida for Ph.D. studies and as a result of his efforts has recently joined with Breathtec Biomedical to propel his own bioanalytical research through the development of revolutionary clinical devices utilizing his background in ion mobility, mass spectrometry, and exhaled breath analysis. Enter your email to get news alerts from Breathtec Biomedical. Enter your email to get news alerts from Breathtec Biomedical. The Company ‹ Mass Spectrometry (MS) helps identify amount and type of molecules in breath sample. Enter your email to get news alerts from Breathtec Biomedical. Careers at Breathtec Biomedical, Inc. Enter your email to get news alerts from Breathtec Biomedical.